A pharma animation for a Multiple Sclerosis drug. MS is a technically hard, medically complicated and a psychologically delicate topic to handle. This is one we were particularly proud of.
"Another neural network," we thought, as we were deciding on images for this page. But our marketing team went to the mat convinced it was one of the "best (explicative) images we've got." Apparently the bright blue is the equivalent of an adult Teletubby for them. Truth to tell, it's one of our favorites too.
Perhaps some of the greatest strides in medicine have been in the area of neurology, neurosurgery, neurochemistry and interventional radiology. Traditionally, an area of medicine with very little interventional capabilities, today, many devices and drugs are in the market, or in the pipeline.
In the last ten years, we have done many animations in this area. We’ve been called upon to show drug development for promising neuro blockbuster drugs, with neural pathways firing, electrical signals jumping across synapses, or showing the MOA on dopamine receptors. We’ve also worked with devices to show treatment of aneurysms and embolisms, or show diagnostic equipment, like gamma ray MRIs. Animating a neural network is particularly interesting as we strive to balance depth of field (the brain has 100 billion neurons) and focus on the main action.
Many of our animations in the therapeutic area of neurology have to do with Central Nervous System disorders. In the past, this has been as MOAs for types of neuro-inhibitors. But in the last five years, nerve stimulation and nerve conduction devices and procedures are increasingly more common. As a result, our medical device division also now has experience with CNS animation.
Are healthcare apps really changing the healthcare landscape? Ashish Khera discusses the trends, the extent to which apps are affecting the industry and the use of 3D in anatomy-related medical apps....See more
504 Bloomfield Avenue, First Floor,
Front, Montclair, NJ07042
2517 Tea Leaf Ln, Tustin, CA 92782